A Review on Process Analytical Technology as a Driver of Pharmaceutical Manufacturing for the Improvement of Quality while Reducing Costs [0.03%]
从改善质量及降低成本的角度探讨过程分析技术对药品制造的推动作用的综述
Ritwik Adak,Arinya Jana,Biplab Debnath et al.
Ritwik Adak et al.
Process analytical technology has emerged as a possible game-changing platform in the pharmaceutical business to improve process knowledge while also improving product quality and lowering production costs. This paper outlines the underlyin...
Identification and Detection of Pharmaceutical Impurities for Ensuring Safety Standard of Medicine: Hyphenated Analytical Techniques and Toxicity Measurements [0.03%]
药物安全标准中的杂质识别与检测：联用技术及其毒性测量
S K Azizuddin,Asif Husain,Mohammad Rashid et al.
S K Azizuddin et al.
Impurity separation and detection are essential processes in the pharmaceutical industry to preserve the quality of drugs as the impurities have the potential to significantly impair the therapeutic efficacy of an active ingredient and have...
Safety Profile of Amantadine: A Comprehensive Analysis of Real-World Adverse Events from the FDA Adverse Event Reporting System Database [0.03%]
金刚烷胺的安全性评估：来自美国食品药品监督管理局不良事件通报系统数据库的meta分析
Wenpei Chen,Xianjun Chen
Wenpei Chen
Background: Traumatic Brain Injury (TBI) is a significant public health issue, often leading to long-term cognitive, physical, and emotional impairments. Amantadine has emerged as a treatment option due to its potential n...
Optimizing Antibiotic use and Awareness in Hospitals: Establishing Effective Antimicrobial Stewardship Pathways [0.03%]
医院抗菌药物优化使用与管理认知：建立有效的抗菌药物管理工作路径
Bianca Maria Donida,Grazia Mingolla,Antonio Manfredi
Bianca Maria Donida
Background: Antibiotic resistance poses a significant challenge in healthcare, requiring effective management of antibiotic use. This study examines systemic antibiotic consumption at ASST Bergamo Ovest, a northern Italia...
Risk Assessment of Amiodarone Use in Patients with Cirrhosis and Heart Failure [0.03%]
肝硬化合并心衰患者使用胺碘酮的风险评估
Kazuhiko Kido,Abdullah Al-Mamun
Kazuhiko Kido
Background: Limited clinical evidence exists regarding the safety profile of amiodarone therapy in patients with heart failure (HF) who already have underlying cirrhosis. ...
Knowledge and Perception of Vaccine Pharmacovigilance and Adverse Events Following Immunization Reporting Among Pharmacy Students in India: An Online-Based Cross-Sectional Study [0.03%]
印度药学专业学生对疫苗药品警戒和接种后不良事件报告的认知与态度：一项基于线上的横断面研究
Vishwa R Byakod,Vijaysanti Deva,Omkar S Pandare et al.
Vishwa R Byakod et al.
Background: In India, the knowledge and perception of vaccine pharmacovigilance and adverse events following immunization (AEFI) reporting among pharmacy students are not clear. ...
Safety Reporting for Auxiliary Medicinal Products in the Sibeprenlimab Phase-III Study According to the New European Union (536/2014) CT Regulation [0.03%]
西布妥昔单抗三期研究辅助类药物的报告(根据新欧盟CT法规536/2014)
Retesh Kumar,Pratyush Giri,Mai Huang et al.
Retesh Kumar et al.
Background: The new European Union clinical trials regulation (EU CTR 536/2014) became effective on 31 January 2022. It introduced the novel concept of Auxiliary Medicinal Products (AxMPs) to be implemented in clinical tr...
Adverse Drug Reactions of Low and Standard Doses of Risperidone in Schizophrenia Outpatients [0.03%]
低剂量与常规剂量利培酮治疗精神分裂症患者的不良反应分析
Tuanthon Boonlue,Praewrawee Karnkla,Sadanan Jansela et al.
Tuanthon Boonlue et al.
Background: Risperidone is an atypical antipsychotic commonly used in the treatment of schizophrenia. Despite its effectiveness, several adverse drug reactions can be bothersome to patients. ...
Pallavi Bassi,Narinderpal Kaur,Shivani Rana et al.
Pallavi Bassi et al.
Pharmacovigilance is the scientific system developed to ensure the overall safety of a medicinal product by precise collection, compilation, and assessment of adverse drug-related events. The review focuses on the accurate evaluation of all...
Tubulointerstitial Nephritis in ANCA-Associated Vasculitis as a Rare Adverse Effect of Adalimumab: A Case Report [0.03%]
ANCA相关性血管炎中adalimumab罕见不良反应的病例报告：结间质性肾炎
Myriam Ayari,Maha Mtir,Ikram Mami et al.
Myriam Ayari et al.
Background: Patients with inflammatory disease treated with biological agents are at an increased risk of developing various adverse effects. However, little is known about the risk of nephrotoxicity, such as induced tubu...